CN1307887A - Medicine composite and its preparation - Google Patents

Medicine composite and its preparation Download PDF

Info

Publication number
CN1307887A
CN1307887A CN 00136175 CN00136175A CN1307887A CN 1307887 A CN1307887 A CN 1307887A CN 00136175 CN00136175 CN 00136175 CN 00136175 A CN00136175 A CN 00136175A CN 1307887 A CN1307887 A CN 1307887A
Authority
CN
China
Prior art keywords
juice
preparation
pharmaceutical compositions
rhizoma chuanxiong
cortex lycii
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN 00136175
Other languages
Chinese (zh)
Other versions
CN1163258C (en
Inventor
孔昭苓
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CNB001361759A priority Critical patent/CN1163258C/en
Publication of CN1307887A publication Critical patent/CN1307887A/en
Application granted granted Critical
Publication of CN1163258C publication Critical patent/CN1163258C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention discloses a medicine composition and its preparation method. Said invented medicine is made of three Chinese medicinal materials of lycium root bark, ligusticum root and cnidium seed through the processes of adding proper quantity of water, reasonable proportioning, soaking, heating at twice and filtering to obtain the invented liquid preparation for curing the diseases of trachitis, angiitis and arthritis. It is simple in preparation process, non-toxic, and has no toxic side effect, and its cure rate is high.

Description

A kind of pharmaceutical composition and preparation method
The present invention relates to a kind of pharmaceutical composition.Be the Chinese patent medicine of feedstock production specifically, the invention still further relates to the preparation method of this medicine with the Chinese herbal medicine.
Tracheitis, vasculitis and arthritis are the common frdquently encountered diseases of serious harm human health, if treat tracheitis, vasculitis and arthritic drug main oral agents at present, defective is that cure rate is low, easily recurrence.
The object of the present invention is to provide a kind of pharmaceutical composition and this preparation of drug combination method, treat tracheitis, vasculitis and arthritis, overcome the deficiency of conventional medicament.
Solution of the present invention is based on motherland's medical science to tracheitis, vasculitis and arthritic pathogenetic understanding and Therapeutic Principle, with reference to the modern pharmacological research achievement, by the theory of Chinese medical science prescription, makes medicine of the present invention.
Pharmaceutical composition of the present invention is made by following component: (consumption is a weight portion)
Cortex Lycii 3-30 Rhizoma Chuanxiong 3-20 Fructus Cnidii 3-25
As improvement, the formulation weight of pharmaceutical composition of the present invention (part) ratio range is:
Cortex Lycii 10-25 Rhizoma Chuanxiong 5-15 Fructus Cnidii 10-20
Optimization formula weight (part) ratio range of pharmaceutical composition of the present invention is:
Cortex Lycii 12-20 Rhizoma Chuanxiong 5-12 Fructus Cnidii 10-15
The production method that above-mentioned each component is made pharmaceutical composition of the present invention is:
(1) Cortex Lycii, Fructus Cnidii, Rhizoma Chuanxiong are taken by weighing by described weight portion proportioning after, add 180-1500 part water purification and soaked 1-2 hour;
(2) heated 1-2 hour down at 90-100 ℃;
(3) leach juice with the 50-80 mesh sieve, as juice A;
The filtering residue of three kinds of Chinese medicines that (4) will filter out adds warm water 120-1000 part water of 50-80 ℃, soaks 5-15 minute;
(5) above-mentioned soaked filtering residue liquid heated 0.5-1 hour down at 90-100 ℃, leached juice with the 50-80 mesh sieve, and mixed with juice A;
(6) mix the juice cooling; Every bottle of 30ml is a fractional pack.
The shelf-life of medicine of the present invention is 2 years.
Pharmaceutical composition of the present invention is a said dosage form in the pharmaceutics.
As improvement, the dosage form of pharmaceutical composition of the present invention is a water preparation.
Smearing the illing skin surface with pharmaceutical composition water preparation of the present invention treats, can treat 1-2 time every day, carry out according to arthritis, vasculitis and arthritic area, put on the skin with absorbent cotton in skin outside and to get final product, about 1 patient needs water preparation 30-60ml, and the lighter uses the 30ml water preparation 7 days course of treatment, 2 recoveries from illness course of treatment of heavy person, effective percentage 85%, cure rate 75%.
The composition of medicine of the present invention and effect are:
Cortex Lycii contains compositions such as betanin Saponin, activating blood circulation to dissipate blood stasis, and be used to disappear eliminating the pathogens from the lung heat, dyspnea and cough due to lung-heat have analgesic antiinflammation, and phlegm and relieving cough, analgesia, antibacterial and anti-inflammation functions are arranged, and external is best.
The Fructus Cnidii warming the kidney to activate YANG is used for chills and pain of the waist and kness, and influenza virus is had inhibitory action, also have that the town is painful, local anesthesia, antipruritic, cough-relieving, remove expectorant, the effect of dispeling the wind.
Rhizoma Chuanxiong contains volatile oil component, wind-expelling pain-stopping, and antithrombotic forms, and coronary blood flow increasing has the microcirculation improvement effect, and antipyretic analgesic, blood-activating and qi-promoting, wind-expelling pain-stopping effect are arranged.
Cortex Lycii, Fructus Cnidii, three kinds of Chinese medicines of Rhizoma Chuanxiong all have activating blood circulation to dissipate blood stasis, the painful cough-relieving in town, analgesicly go to ache, antiinflammation, and three kinds of compound external curing tracheitiies of Chinese medicine, vasculitis, arthritis have good effect.
The clinical use result of pharmaceutical composition of the present invention shows that following advantage is arranged: this medicine is a Chinese medicine preparation, is used for the illing skin surface outward, and nontoxic, side effect is safe and convenient to use; Used raw material of Chinese medicine kind is fewer, and preparation method is comparatively simple.
For showing pharmaceutical composition of the present invention to treatment tracheitis, vasculitis, arthritic therapeutic effect, the present invention is through 53 routine system clinical treatments, wherein male 36 examples, women 17 examples, 1-2 the course of treatment.
Administrated method: every day 1-2 time, each 1-1.5 hour.
Embodiments of the invention are provided below
Embodiment
Take by weighing raw material (gram) by following proportioning:
Cortex Lycii 18 Rhizoma Chuanxiongs 15 Fructus Cnidiis 15
Production method is as follows:
(1) Cortex Lycii, Fructus Cnidii, Rhizoma Chuanxiong are taken by weighing by described weight portion proportioning after, add 960 grams
Water purification soaked 1.5 hours;
(2) heated 1.5 hours down at 90-100 ℃;
(3) leach juice with the 50-80 mesh sieve, as juice A;
The filtering residue of three kinds of Chinese medicines that (4) will filter out adds 60 ℃ warm water 640 gram water, soaks 10 minutes;
(5) above-mentioned soaked filtering residue liquid was heated 1 hour down at 90-100 ℃, use the 50-80 mesh sieve
Leach juice, and mix with juice A.
(6) will mix the juice cooling;
(7) every bottle of 30ml is a fractional pack.
Treatment tracheitis of the present invention, vasculitis, arthritic some cases are provided below.
Case 1 Zhu Yonglin man 51 years old, people from Heilongjiang Province suffered from vasculitis more than 20 year, can not stand, and through failing to respond to any medical treatment for many years, carried out the treatment of two courses of treatment in July, 2000, and with medicinal agent 50ml of the present invention, originally the vascular of varicose recovers normal, and can run morning.
Case 2 Xu intellectual circle men 36 years old, people from Heilongjiang Province, suffering from asthma anaphylaxis tracheitis has 15 years, and can not go out winter, and hospitalization is invalid several times, with medicinal agent 60ml treatment of the present invention recovery from illness in 16 days.
Case 3 Wang Ying woman 52 years old, people from Jilin Province suffers from arthritis for many years, can not go to work in the time of 45 years old, fails to respond to any medical treatment through many-side, and in May, 1998 is with fully recovering around the medicinal agent 90ml treatment of the present invention.

Claims (6)

1 one kinds of pharmaceutical compositions is characterized in that it is the medicament of being made by the following weight proportion raw material
Cortex Lycii 3-30 Rhizoma Chuanxiong 3-20 Fructus Cnidii 3-25
2 pharmaceutical compositions according to claim 1, wherein the weight proportion of each raw material is
Cortex Lycii 10-25 Rhizoma Chuanxiong 5-15 Fructus Cnidii 10-20
3 pharmaceutical compositions according to claim 1, wherein the weight proportion of each raw material is
Cortex Lycii 12-20 Rhizoma Chuanxiong 5-12 Fructus Cnidii 10-15
4 according to claim 1,2 or 3 described pharmaceutical compositions, it is characterized in that said medicament is pharmaceutically said dosage form.
5 pharmaceutical compositions according to claim 4 is characterized in that said medicament is a water preparation.
The described preparation of drug combination method of 6 claim 5 is characterized in that
(1) Cortex Lycii, Fructus Cnidii, Rhizoma Chuanxiong are taken by weighing by described weight portion proportioning after, add 180-1500 part water purification and soaked 1-2 hour;
(2) heated 1-2 hour down at 90-100 ℃;
(3) leach juice with the 50-80 mesh sieve, as juice A;
The filtering residue of three kinds of Chinese medicines that (4) will filter out adds warm water 120-1000 part water of 50-80 ℃, soaks 5-15 minute;
(5) above-mentioned soaked filtering residue liquid heated 0.5-1 hour down at 90-100 ℃, leached juice with the 50-80 mesh sieve, and mixed with juice A;
(6) mix the juice cooling and make water preparation.
CNB001361759A 2000-12-27 2000-12-27 Medicine composite and its preparation Expired - Fee Related CN1163258C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB001361759A CN1163258C (en) 2000-12-27 2000-12-27 Medicine composite and its preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB001361759A CN1163258C (en) 2000-12-27 2000-12-27 Medicine composite and its preparation

Publications (2)

Publication Number Publication Date
CN1307887A true CN1307887A (en) 2001-08-15
CN1163258C CN1163258C (en) 2004-08-25

Family

ID=4597109

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB001361759A Expired - Fee Related CN1163258C (en) 2000-12-27 2000-12-27 Medicine composite and its preparation

Country Status (1)

Country Link
CN (1) CN1163258C (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003053167A1 (en) * 2001-12-11 2003-07-03 Societe Des Produits Nestle S.A. Composition for promotion of bone growth and maintenance of bone health
CN103301260A (en) * 2013-05-27 2013-09-18 布焕景 External use medicine for treating arthritic and preparation method thereof
CN104027641A (en) * 2014-06-04 2014-09-10 烟台瑞智生物医药科技有限公司 Traditional Chinese medicine for treating damp heat syndrome type angiitis

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003053167A1 (en) * 2001-12-11 2003-07-03 Societe Des Produits Nestle S.A. Composition for promotion of bone growth and maintenance of bone health
EP1325681A1 (en) * 2001-12-11 2003-07-09 Société des Produits Nestlé S.A. Composition for promotion of bone growth and maintenance of bone health
EP2135517A1 (en) * 2001-12-11 2009-12-23 Société des Produits Nestlé S.A. Composition for promotion of bone growth and maintenance of bone health
EP2263480A1 (en) * 2001-12-11 2010-12-22 Société des Produits Nestlé S.A. Composition for promotion of bone growth and maintenance of bone health, comprising Mentha extracts
EP2272382A1 (en) * 2001-12-11 2011-01-12 Société des Produits Nestlé S.A. Composition for promotion of bone growth and maintenance of bone health, comprising soybean or soybean extracts
EP2286675A1 (en) * 2001-12-11 2011-02-23 Société des Produits Nestlé S.A. Composition for promotion of bone growth and maintenance of bone health
CN103301260A (en) * 2013-05-27 2013-09-18 布焕景 External use medicine for treating arthritic and preparation method thereof
CN104027641A (en) * 2014-06-04 2014-09-10 烟台瑞智生物医药科技有限公司 Traditional Chinese medicine for treating damp heat syndrome type angiitis

Also Published As

Publication number Publication date
CN1163258C (en) 2004-08-25

Similar Documents

Publication Publication Date Title
CN1814245A (en) Chinese medicine remedy for treating cervical vertebra disease
CN1502350A (en) Traditional Chinese medicine composition (Fujangtieda liquor) for curing traumatic injury
CN1899518A (en) External use Chinese medicine for treating burn and scold and its preparing method
CN1163258C (en) Medicine composite and its preparation
CN1074676C (en) Medicine for treating rheumatic arthritis and hyperosteogeny and preparing process thereof
CN1478525A (en) Medicated wine for treating traumatic injury
CN107050242B (en) Traditional Chinese medicine composition for treating acute soft tissue injury, preparation method and application thereof
CN1895593A (en) Medicine for treating acne and its preparation
CN1589820A (en) Chinese medicinal infusion for treating shingles, parotitis acute mamitis and its manufacturing method
CN1181878C (en) Detumescence plaster
CN1530122A (en) Chinese medicine for treating injury
CN1229118C (en) Bone setting machine
CN1297309C (en) External medicine composition for curing arthralgia-syndrome of joint and preparation process thereof
CN1490018A (en) Medicine for treating rheumatic disease
CN1087618C (en) Medicine for treating allergic rhinitis
CN111700977B (en) Traditional Chinese medicine composition for promoting fracture healing and preparation method and application thereof
CN110946903B (en) Traditional Chinese medicine composition for preventing and treating systemic sclerosis and application thereof
CN102319324A (en) Medicine for treating beriberi
CN1143684C (en) Medicine for treating hypertension and heart disease and its preparation
CN1085093C (en) Traditional Chinese medicine oral liquor for treating male infertility
CN1273167C (en) Medicine for external application for curing rheumatism and its preparation method
CN1086140C (en) Cleaning liquid for treating tinear and its preparing process
CN1246019C (en) Chinese medicine preparation for curing angitis
CN1060394C (en) Process for preparing prescription and medicinal extract of plaster for activating meridians
CN1090196A (en) Liquid for curing bone fracture

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee